JAKAVI 5MG TAB

Overview

JAKAVI 5MG TAB is a Schedule H drug.

JAKAVI 5MG TAB is composed of: RUXOLITINIB (5.0 MG)

Ruxolitinib works by blocking certain enzymes in the body that affect blood cell production. Ruxolitinib is used to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that affect your body’s ability to produce blood cells.

Usage

RUXOLITINIB is generally used to treat: Myelofibrosis, Polycythemia Vera

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Not Safe

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Not enough studies to prove Risk – Ask your Doctor

Q: Is it safe to take for someone breastfeeding?
A: Check with your Doctor first

Precautions for JAKAVI 5MG TAB and its Constituents

Caution should be exercised in patients with history of liver or kidney impairment, patients on dialysis, during pregnancy and breastfeeding. It may cause dizziness, avoid performing any hazardous activity while taking this medication. Patient may develop with certain types of infection; discuss with your healthcare provider before taking this medication. It may reduce platelet counts; avoid injury or bruising. Monitor complete blood count regularly while taking this medication.

Symptoms of Overdosage

RUXOLITINIB over-dosage can result in: Difficulty Breathing

Common Side-Effects

RUXOLITINIB : Black (tar) Colored Stools, Gums Bleeding, Blood Or Red Colored Urine, Chills, Cough, Fever, Frequent Urge To Urinate, Pale Skin, Shortness Of Breath, Throat Soreness, Fatigue (tiredness), Weakness (generalized)

Serious Side-Effects

RUXOLITINIB : Seizures (uncontrollable Jerking Of Limbs), Slurred Speech

Rare Side-Effects

RUXOLITINIB : Dizziness, Difficulty Breathing, Face Swelling

Disease Interactions

RUXOLITINIB can interfere with: Acute Liver Failure, Hepatitis, Bacterial Infection, Fungal Infection, Hyperlipidemia, Acute Renal Failure, Tuberculosis, Latent Tuberculosis

Technical Classification

RUXOLITINIB is categorized as: MULTIKINASE INHIBITORS / ANTINEOPLASTICS

Available Alternatives for JAKAVI 5MG TAB

What are the commonly available Substitutes?

JAKAVI 5MG TAB

INR 24999 for 14 TABLETS

RUXOLITINIB 5.0 MG

What are the other drugs with similar Ingredients?

JAKAFI 20MG TAB	INR for	RUXOLITINIB 20 MG
JAKAVI 15MG TAB	INR 56547.62 for 14 TABLETS	RUXOLITINIB 15.0 MG
JAKAVI 20MG TAB	INR 59520.23 for 14 TABLETS	RUXOLITINIB 20.0 MG
RUXOLITINIB		RUXOLITINIB